menu icon
close icon

Corporate site

  • Статьи
    Популярные статьи
    Последние статьи
    • -
    • -
Расширенный поиск


Абстракт

Сопроводительное письмо

Фигуры

Ключевые слова

Ссылки

  1. Saver JL. Time is brain -- quantified. Stroke. 2006;;37::263––266.. doi: 10.1161/01.STR.0000196957.55928.ab. 
  2. Powers WJ,, Rabinstein AA,, Ackerson T,, Adeoye OM,, Bambakidis NC,, Becker K,, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018;;49::e46.. doi: 10.1161/STR.0000000000000158. 2018. 
  3. Lansberg MG,, O'Donnell MJ,, Khatri P,, Lang ES,, Nguyen-Huynh MN,, Schwartz NE,, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;;141::e601S.. doi: 10.1378/chest.11-2302.
  4. Group NS. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA stroke study group. N Engl J Med. 1995;;333((24):):1581––1587.. doi: 10.1056/NEJM199512143332401. 
  5. Hacke W,, Donnan G,, Fieschi C,, Kaste M,, von Kummer R,, Broderick JP,, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;;363((9411):):768––774. doi: 10.1016/S0140-6736(04)15692-4. 
  6. Hacke W,, Kaste M,, Bluhmki E,, Brozman M,, Dávalos A,, Guidetti D,, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;;359((13):):1317––1329.. doi: 10.1056/NEJMoa0804656. 
  7. Emberson J,, Lees KR,, Lyden P,, Blackwell L,, Albers G,, Bluhmki,, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. The Lancet, 384((9958),):pp.1929––1935.. doi: 10.1016/S0140-6736(14)60584-5. 2014. 
  8. Norrving et al. Action plan for stroke in Europe 2018–2030. Eur Stroke J (2018)
  9. Plan de atención de los pacientes con ictus en la Comunidad de Madrid. Dirección General de Proceso Integrado de Salud Servicio Madrileño de Salud (2021).
  10. Langhorne et al. Organised inpatient (stroke unit) care for stroke: network meta-analysis. Cochrane Database Syst Rev. (2020)
  11. E. Díez-Tejedor et al. Acute care in stroke: do stroke units make the difference? Cerebrovasc Dis (2001)
  12. S. Pastor et al. Development of the Madrid Stroke Programme: milestones and changes in stroke trends and mortality from 1997 to 2017. Neuroepidemiology (2021)
  13. National Institute of Neurological Disorders et al. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med (1995)
  14. W. Hacke et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke N Engl J Med (2008)
  15. W.J. Powers et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke (2019)
  16. E. Berge et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke Eur Stroke J (2021)
  17. S. Yaghi et al. Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2017)
  18. J. Sun et al. Risk factors of hemorrhagic transformation in acute ischaemic stroke: a systematic review and meta-analysis. Front Neurol (2023)
  19. R. Hurford et al. Incidence, predictors and clinical characteristics of orolingual angio-oedema complicating thrombolysis with tissue plasminogen activator for ischaemic stroke. J Neurol Neurosurg Psychiatry (2015)
  20. A.M. Burgos et al. Evidence that tenecteplase is noninferior to alteplase for acute ischemic stroke: meta-analysis of 5 randomized trials. Stroke (2019)
  21. B.C.V. Campbell et al. Tenecteplase versus alteplase before thrombectomy for ischemic stroke. N Engl J Med (2018)

О статье:

История публикации

Опубликовано: 14.Sep.2024

DOI: https://doi.org/10.28942/ajim.v1i1y2024.19

Авторское право

2022-2025 Azerbaijan İnternal Medicine Society. Published by "Uptodate In Medicine" health sciences publishing. All rights reserved.

Связанные статьи

Связанные статьи не найдены

Просмотрено: 803